UK Stocks-Factors to watch on March 1

March 1 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening 31.21 points lower at 7,458 on Tuesday, according to financial bookmakers.

* CRODA: British speciality chemicals group Croda CRDA.L reported a 48% jump in annual profit on Tuesday, helped by strong growth in its life sciences division and a rebound in demand for cosmetics, which propped up its personal-care unit.

* ASTRAZENECA: AstraZeneca Plc AZN.L said on Tuesday it had agreed with Swiss biotechnology firm Neurimmune to develop an antibody-based therapy for a rare, underdiagnosed condition that can lead to heart failure in a deal valued up to $760 million.

* SHELL: Shell Plc SHEL.L said on Tuesday Jessica Uhl has resigned as its finance chief after five years in the role and will be replaced by Sinead Gorman.

* BROOKFIELD: Britain's competition regulator cleared Brookfield's proposed acquisition of a minority stake in Scotia Gas Networks (SGN) without referring the $1.7 billion deal to a lengthy investigation.

* ABRDN: British asset manager abrdn ABDN.L reported a 47% rise in 2021 operating profit to 323 million pounds ($433.53 million), it said on Tuesday, helped by strong market performance.

* MAN GROUP: Man Group said on Tuesday that assets under management rose 20% to a record $148.6 billion in 2021, helping the British-based hedge fund to more than double its core earnings per share.

* REACH PLC: British news publisher Reach RCH.L said higher inflation, particularly in newsprint, would result in a modest reduction in operating profit this year on revenue that would remain steady, as growth in digital offsets declines in its printed newspapers.

* FLUTTER: Flutter FLTRF.I posted an 11% fall in earnings for 2021 excluding its heavy investment in the United States, at the lower end of its forecast range following a winning streak for betters, regulatory changes and increased spending on problem gambling.

* LSE: The London Stock Exchange said on Tuesday it will stop trading in two global depository receipts (GDRs) for Russia's VTB Bank VTBR.MM after Britain's financial regulator suspended them in response to sanctions.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Amna Karimi in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.